Article
Detection of recurrent alternative splicing switches in tumor samples reveals novel signatures of cancer.
Nucleic acids research - 18 Feb 2015
Sebestyén Endre, Zawisza Michał, Eyras Eduardo
Abstract excerpt
The determination of the alternative splicing isoforms expressed in cancer is fundamental for the development of tumor-specific molecular targets for prognosis and therapy, but it is hindered by the heterogeneity of tumors and the variability across patients. We developed a new computational method, robust to biological and technical variability, which identifies significant transcript isoform changes across...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
